Compare Stocks

→ Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNE Blue Horizon BNE ETF	$22.10 +0.9%	$22.09	$19.53 ▼ $27.62	$4.97M	1.32	588 shs	300 shs
GXE Gear Energy	C$0.68 +1.5%	C$0.66	C$0.60 ▼ C$1.07	C$178.33M	3.73	350,949 shs	72,897 shs
IBR Iron Bridge Resources		C$0.84	C$0.46 ▼ C$0.85	C$130.05M	N/A	311,087 shs	86,099 shs
PHAR Pharming Group	$9.53 -8.8%	$10.86	$9.27 ▼ $16.71	$639.56M	0.16	2,591 shs	1,201 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNE Blue Horizon BNE ETF	0.00%	+1.39%	-1.82%	+4.09%	-7.98%
GXE Gear Energy	+1.52%	+3.08%	+4.69%	+1.52%	-34.31%
IBR Iron Bridge Resources	0.00%	0.00%	0.00%	0.00%	0.00%
PHAR Pharming Group	-2.93%	-0.16%	-11.36%	-22.01%	-11.81%

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNE Blue Horizon BNE ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	3.0202 of 5 stars	3.3	0.0	1.7	0.0	1.8	1.7	1.9
IBR Iron Bridge Resources	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	2.6126 of 5 stars	3.5	5.0	0.0	0.0	2.6	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNE Blue Horizon BNE ETF	0.00	N/A	$23.13	4.67% Upside
GXE Gear Energy	2.50	Moderate Buy	C$1.00	47.06% Upside
IBR Iron Bridge Resources	N/A	N/A	N/A	N/A
PHAR Pharming Group	3.00	Buy	$37.00	288.25% Upside

Current Analyst Ratings

Latest IBR, PHAR, PTAL, GXE, and BNE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/14/2024	PHAR Pharming Group	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$37.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNE Blue Horizon BNE ETF	N/A	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	C$129.82M	1.37	C$0.00 per share	540.00	C$0.90 per share	0.76
IBR Iron Bridge Resources	C$21.83M	0.00	N/A	N/A	C$0.56 per share	0.00
PHAR Pharming Group	$245.32M	2.61	$0.09 per share	100.85	$3.26 per share	2.92

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNE Blue Horizon BNE ETF	N/A	N/A	13.26	∞	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	C$8.59M	C$0.03	22.67	∞	N/A	6.61%	3.52%	4.05%	5/1/2024 (Estimated)
IBR Iron Bridge Resources	N/A	-C$1.03	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	-$10.55M	-$0.14	N/A	N/A	N/A	-4.13%	-4.53%	-2.14%	5/8/2024 (Confirmed)

Latest IBR, PHAR, PTAL, GXE, and BNE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/8/2024	N/A	PHAR Pharming Group	$0.0050	N/A	-$0.0050	N/A	N/A	N/A
3/14/2024	Q4 2023	PHAR Pharming Group	$0.05	-$0.03	-$0.08	-$0.02	$71.83 million	$81.20 million
2/21/2024	Q4 2023	GXE Gear Energy	C$0.02	-C$0.03	-C$0.05	-C$0.03	N/A	C$37.52 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNE Blue Horizon BNE ETF	$0.06	0.27%	N/A	N/A	N/A
GXE Gear Energy	C$0.06	8.82%	N/A	200.00%	N/A
IBR Iron Bridge Resources	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	N/A	N/A	N/A	N/A	N/A

Latest IBR, PHAR, PTAL, GXE, and BNE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/1/2024	GXE Gear Energy	Monthly	C$0.01	9.09%	4/12/2024	4/15/2024	4/30/2024
3/4/2024	GXE Gear Energy	Monthly	C$0.01	9.09%	3/14/2024	3/15/2024	3/29/2024
2/14/2024	GXE Gear Energy	Monthly	C$0.01	9.23%	2/14/2024	2/29/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNE Blue Horizon BNE ETF	N/A	N/A	N/A
GXE Gear Energy	8.94	1.04	0.56
IBR Iron Bridge Resources	4.61	0.46	0.43
PHAR Pharming Group	0.62	4.06	3.33

Ownership

Institutional Ownership

Company	Institutional Ownership
BNE Blue Horizon BNE ETF	N/A
GXE Gear Energy	2.43%
IBR Iron Bridge Resources	N/A
PHAR Pharming Group	0.03%

Insider Ownership

Company	Insider Ownership
BNE Blue Horizon BNE ETF	N/A
GXE Gear Energy	7.06%
IBR Iron Bridge Resources	N/A
PHAR Pharming Group	2.07%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BNE Blue Horizon BNE ETF	N/A	225,000	N/A	Not Optionable
GXE Gear Energy	30	262.25 million	N/A	Not Optionable
IBR Iron Bridge Resources	N/A	154.82 million	N/A	Not Optionable
PHAR Pharming Group	332	67.11 million	65.72 million	Not Optionable

IBR, PHAR, PTAL, GXE, and BNE Headlines

Source	Headline
	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards finance.yahoo.com - April 24 at 2:17 AM
	Pharming Group to report first quarter 2024 financial results on May 8 finance.yahoo.com - April 24 at 2:17 AM
	Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.00 marketbeat.com - April 22 at 1:31 PM
	Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? zacks.com - April 22 at 6:31 AM
	Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase americanbankingnews.com - April 21 at 4:44 AM
	Pharming Group (NASDAQ:PHAR) Hits New 1-Year Low at $9.35 americanbankingnews.com - April 20 at 4:40 AM
	Pharming Group N.V.: Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 finanznachrichten.de - April 19 at 4:05 PM
	Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume marketbeat.com - April 19 at 1:37 PM
	Pharming Group N.V.: Pharming Group announces the placement of €100 million convertible bonds due 2029 finanznachrichten.de - April 18 at 6:18 PM
	Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 finance.yahoo.com - April 18 at 8:17 AM
	Pharming Group (NASDAQ:PHAR) Stock Price Down 6.8% marketbeat.com - April 15 at 1:55 PM
	Pharming Group (NASDAQ:PHAR) Shares Down 5% marketbeat.com - April 9 at 3:19 PM
	Enrollment completed for trial of drug to treat children with rare primary immunodeficiency outsourcing-pharma.com - April 8 at 8:50 AM
	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib finance.yahoo.com - April 8 at 1:34 AM
	Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.96 marketbeat.com - April 4 at 6:21 PM
	Pharming Group announces the filing of its 2023 Annual Report and Form 20-F finance.yahoo.com - April 4 at 1:14 AM
	Uber to pay $178 million in Australia taxi class action settlement msn.com - March 18 at 3:45 AM
	Pharming reports Q4 results msn.com - March 15 at 7:46 PM
	Pharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation seekingalpha.com - March 14 at 9:06 AM
	Pharming Group N.V.: Pharming Group to report fourth quarter and full year 2023 financial results on March 14 finanznachrichten.de - February 29 at 6:26 AM
	Pharming Group N.V. (PHGN.F) finance.yahoo.com - February 20 at 3:10 PM
	Pharming Group N.V.: Pharming Group to participate in February investor conferences finanznachrichten.de - February 8 at 3:55 AM
	Pharming Group to participate in February investor conferences finance.yahoo.com - February 8 at 3:55 AM
	Astria Therapeutics: Too Much Risk, Too Little Reward Despite Near-Term Data Readout seekingalpha.com - February 5 at 12:52 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Alphabet and Microsoft jump to push Wall Street higher
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft jump to push Wall Street higher
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
April 3, 2024 9:10 AM
View Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 9, 2024 6:07 AM
View Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Biotech Sector Nears Breakout: Will it Outperform in Q2?
April 3, 2024 6:10 AM
View Biotech Sector Nears Breakout: Will it Outperform in Q2?

All Headlines

Company Descriptions

Blue Horizon BNE ETF

NYSEARCA:BNE

The Blue Horizon BNE ETF (BNE) is an exchange-traded fund that is based on the Blue Horizon New Energy Economy 100 index. The fund tracks an equal-weighted index of global stocks that are perceived to benefit from a New Energy Economy. BNE was launched on Dec 8, 2020 and is managed by Blue Horizon.

Gear Energy

TSE:GXE

Gear Energy Ltd., an exploration and production company, engages in the acquiring, developing, and holding of interests in petroleum and natural gas properties and assets in Canada. The company's oil properties are located in Central Alberta, West Central Saskatchewan, and Southeast Saskatchewan. Gear Energy Ltd. is headquartered in Calgary, Canada.

Iron Bridge Resources

TSE:IBR

Iron Bridge Resources Inc. engages in the exploration, development, and production of natural gas, crude oil, and natural gas liquids in Western Canada. It primarily operates in the Montney light oil fairway at Elmworth in West Central Alberta. As of December 31, 2017, its total proved plus probable reserves included 26.11 million barrels of oil equivalent. The company was formerly known as RMP Energy Inc. and changed its name to Iron Bridge Resources Inc. in November 2017. Iron Bridge Resources Inc. is headquartered in Calgary, Canada. As of October 5, 2018, Iron Bridge Resources Inc. operates as a subsidiary of Velvet Energy Ltd.

Pharming Group

NASDAQ:PHAR

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial